Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.
Rimidi is a health IT platform that enables virtual, personalized management of cardiometabolic diseases.
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
Recludix pharma is a developing platform to treat cancer patients.
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.
Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.
Crossbow Therapeutics is a biotech company developing a new type of cancer treatment.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Eli Lilly has invested in 158 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Life Science, Therapeutics, Medical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Sanegene Bio received $110.0M in a Series B round. Eli Lilly's total known invested capital is $7.3B.
Eli Lilly's average investment size is $55.2M across its portfolio of 158 companies.
Recent Eli Lilly portfolio additions include Juvena Therapeutics, Rimidi, Fountain Therapeutics, Rezo Therapeutics, Gate Bioscience. These companies were founded in 2020 or later.